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The extensive production and use of
organohalogen substances (OHS), including
polychlorinated biphenyls (PCBs), 2,2-bis(4-
chlorophenyl)-1,1,1-trichloroethane (4,4´-
DDT), and pentachlorophenol (PCP), have
resulted in their ubiquitous distribution in
the environment. In particular, closed aquat-
ic ecosystems, such as the Baltic Sea, have
become heavily polluted by OHS (1). 2,2-
Bis(4-chlorophenyl)-1,1-dichloroethene
(4,4´-DDE) and PCBs have been and are
still the major environmental contaminants
in this geographic area. Correlated toxic
effects have been observed among white-
tailed sea eagles (2,3) and in seals living in
the Baltic Sea area (4,5). 
Metabolites of OHS, and in particular of
PCB and DDT, may play a central role in
producing such toxic effects. PCB methyl
sulfones (MeSO2-PCBs) and polychloro-
biphenylols (OH-PCBs) are major metabo-
lites of PCB and are found in humans and
wildlife at comparatively high concentrations
(6). Other pollutants of concern in the case
of the Baltic Sea are the polybrominated
diphenyl ethers (PBDEs) and hexachloroben-
zene (HCB) (7). The levels of the OHS
detected in Baltic wildlife at high trophic lev-
els range from low to high parts per million
per lipid weight, with the highest concentra-
tions being demonstrated by 4,4´-DDE and
certain persistent PCB congeners. For exam-
ple, the levels of 4,4´-DDE, 2,2´,4,4´,5,5´-
hexachlorobiphenyl (CB-153), 2,2´,4,4´-
tetrabromodiphenyl ether (BDE-47), and
HCB in salmon (Salmo salar) from the Baltic
Sea, caught in a Swedish river in 1995, were
3,200, 1,100, 200, and 95 ng/g lipid weight,
respectively (7). The Swedish program for
monitoring changes in the concentrations of
DDT, PCB, HCB, and hexachlorocyclo-
hexane in Baltic wildlife species has revealed
signiﬁcant decreases since the 1970s (8).
This contamination of the Baltic Sea has
resulted in higher levels of persistent OHS in
humans who consume large quantities of
local fatty fish (9,10). Asplund et al. (9)
reported that plasma levels of 4,4´-DDE and
CB-153 were 4,500 and 1,000 ng/g lipid
weight, respectively, in Swedish men with an
average fatty fish consumption of about
2,700 g/month (corresponding to approxi-
mately 12 fish meals/month). This 4,4´-
DDE concentration was 6-fold greater than
in men who did not eat any ﬁsh, whereas the
corresponding difference for the persistent
CB-153 was 2-fold.
Both age and period of lactation exerted a
major inﬂuence on plasma PCB levels in a
group of 50 ﬁshermen’s wives, whereas only a
weak inﬂuence from consumption of ﬁsh was
observed (10). Since the beginning of the
1970s, contamination in Swedish women in
general has been monitored by analyzing the
levels of a large number of OHS in mother’s
milk (11–13). With regard to the OHS stud-
ied here, decreases in the levels of 4,4´-DDE,
CB-153, and HCB in mother’s milk have
been reported, with the mean levels of these
substances in the early 1990s being 230, 96,
and 31 ng/g lipid weight, respectively (12).
In contrast, exponentially increasing levels of
BDE-47 and other PBDE congeners have
recently been reported (13). However, the
concentration of BDE-47 in milk pooled
from different mothers in 1997 was still low
(2.3 ng/g lipid weight) compared to that of,
for example, CB-153 (96 ng/g lipid weight)
(12,13).
The phenolic OHS (e.g., PCP and OH-
PCBs) examined in the present study are
present in the blood of humans and wildlife,
primarily bound to serum proteins. Phenolic
OHS can compete for binding to the thy-
roxin (T4) binding site in transthyretin
(TTR), a T4 transporting protein (14),
and/or bind due to binding to other blood
proteins (15). In a group of 120 women
from six different municipalities in Sweden,
the average PCP plasma concentration in the
mid-1980s was 4,000 ng/g lipid weight
(range 970–12,000 ng/g) (16). PCP is also
detected in salmon blood at a level of 1,200
ng/g lipid weight (range 880–1,800 ng/g),
although the corresponding level in muscle
is much lower, (32 ng/g lipid weight; range
16–64 ng/g) (7). Retention of OH-PCBs in
the blood of humans and wildlife was ﬁrst
reported in the mid-1990s (17). Five OH-
PCB congeners predominate in human
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Articles
We examined the inﬂuence of widely varied consumption of fatty ﬁsh from the Baltic Sea and of
age on plasma concentrations of polychlorinated biphenyls (PCBs), polychlorobiphenylols (OH-
PCBs), 2,2-bis(4-chlorophenyl)-1,1,1-trichloroethane (4,4´-DDT), 2,2-bis(4-chlorophenyl)-1,1-
dichloroethane (4,4´-DDE), 2,2´,4,4´-tetrabromodiphenyl ether (BDE-47), hexachlorobenzene
(HCB), and pentachlorophenol (PCP) in Latvian and Swedish men. Both age and ﬁsh consump-
tion were signiﬁcantly correlated with the concentrations of ΣPCB, ΣOH-PCB, 4,4´-DDE, 4,4´-
DDT, and HCB. In the case of BDE-47, no signiﬁcant relationship with age was observed, and
ﬁsh consumption had the largest relative effect on plasma concentrations of this contaminant.
This relationship may be a result of exposure to BDE-47 having been more recent than that of
PCBs and DDE, or because the half-life of BDE-47 may be shorter than that of PCB and DDE.
Latvian men demonstrated higher plasma levels of DDE and DDT but lower levels of ΣPCB and
PCP than did Swedish men. The corresponding levels of HCB and BDE-47 were similar in both
countries. The Spearman’s rank correlation coefﬁcient obtained by comparing the level of the
metabolite 4-hydroxy-2,3,3´,4´,5-pentachlorobiphenyl (4-OH-CB107) to the combined levels of
its parent compounds, 2,3,3´,4,4´-pentachlorobiphenyl (CB-105) and 2,3´,4,4´,5-pentachloro-
biphenyl (CB-118), was higher than the median correlation coefﬁcient obtained upon comparing
the level of this metabolite to all other possible combinations of two PCB levels. No other
increased correlation between metabolite and parent PCB concentration was observed. Key words:
endocrine disruptors, fish consumption, hexachlorobenzene, pentachlorophenol, polychloro-
biphenylols, polybrominated diphenyl ethers, thyroid hormone. Environ Health Perspect
108:1035–1041 (2000). [Online 10 October 2000]
http://ehpnet1.niehs.nih.gov/docs/2000/108p1035-1041sjodin/abstract.htmlblood, and the plasma levels of these hydrox-
ylated derivatives are lower than those of the
most persistent PCB congeners (17).
Risk for neurodevelopmental and repro-
ductive toxicity and endocrine disruption in
humans from dietary exposure to OHS has
received increasing attention (18). Similarly,
potential risk for immunosuppression and
cancer caused by OHS are of concern
(19,20). A prerequisite for conducting reliable
epidemiologic studies designed to evaluate
these risks is the availability of well-character-
ized OHS exposure markers.
The major objective of the present inves-
tigation was to relate OHS concentrations in
the plasma of Latvian and Swedish men to
ﬁsh consumption, age, and country of ori-
gin. In addition, this study was designed to
determine the levels of the predominant
OH-PCBs present in human blood and to
compare these levels to those of the parent
PCB congeners. Furthermore, the level of
the more recent environmental contaminant
BDE-47, the major PBDE congener present
in environmental samples, was determined
and compared to the levels of other major
environmental pollutants known to be pre-
sent in humans.
Materials and Methods
Chemicals. The reference compounds used
for preparation of standard solutions, their
abbreviations, and their sources of origin are
listed in Table 1. The internal surrogate
standards used were CB-189 for quantita-
tion of PCBs, 4,4´-DDE, 4,4´-DDT, and
HCB; 4-OH-CB193 for quantitation of
OH-PCBs; and 2,3,4-trichlorophenol
(2,3,4-triCP) for quantitation of PCP. A
volumetric standard BDE-128 was added for
quantitation of BDE-47.
Hexane (distol grade; Fisher Scientific,
Leicestershire, UK); methyl tert-butyl
ether (MTBE; HPLC grade; Rathborn,
Walkerburn, Scotland); 2-propanol [analyti-
cal (p.a.) grade; Prolabo, Cedex, France]; sil-
ica gel 60 (0.063–0.200 mm), sulfuric acid,
and hydrochloric acid (p.a. grade; Merck,
Darmstadt, Germany); and potassium
hydroxide (p.a. grade; Eka Nobel, Bohus,
Sweden) were used. Diazomethane, used for
derivatization of phenolic compounds, was
prepared from N-methyl-N-nitroso-p-tolue-
nesulfonamide (Dielsald) (24) obtained
from Sigma-Aldrich (Steinheim, Germany).
Instrumentation. Gas chromatography
with electron capture detection (GC-ECD)
was performed on a Varian 3400 gas chro-
matograph (Varian, Walnut Creek, CA,
USA) using a DB-5 capillary column (30 m
× 0.25 mm i.d., 0.25 µm phase thickness;
J&W Scientific, Folsom, CA, USA).
Hydrogen was used as the carrier gas and
nitrogen as the make-up gas. Injections were
performed in the splitless mode. The column
oven temperature was programmed as fol-
lows: 80°C (2 min), 10°C/min up to 300°C
(5 min). The injector and detector tempera-
tures were 250°C and 360°C, respectively.
Data were collected and processed using a
PC-based ELDSPro v1.0 system (Chromato-
graphic Data System AB, Stockholm,
Sweden).
Gas chromatography/mass spectrometry
(GC/MS) was performed using a Finnigan
TSQ 700 (TermoQuest, Bremen, Germany)
connected to a Varian 3400 gas chromato-
graph fitted with a DB-5HT capillary col-
umn (15 m × 0.25 mm i.d., 0.10 µm phase
thickness; J&W Scientiﬁc) and with helium
as the carrier gas. Splitless injections were
performed at an injector temperature of
260°C. The column oven temperature was
programmed as follows: 80°C (1 min),
15°C/min up to 300°C (10 min). The ion
source temperature was 200°C and the pres-
sure was 6.5 torr. The instrument was operat-
ed in the electron capture negative ionization
(ECNI) mode with a primary electron energy
of 70 eV. Selected ion monitoring (SIM) of
the bromine isotopes, m/z 79 and 81, was
carried out (25). Methane (AGA, Stockholm,
Sweden) of ≥ 99.995% purity and contain-
ing ≤ 5 ppm O2 was used as the electron
thermalization buffer gas.
Study groups and sampling of plasma. We
actively recruited the study groups to obtain a
large interindividual contrast in consumption
of fatty Baltic Sea ﬁsh, mainly salmon and
herring. In 1991, 43 men (median age 42
years, range 23–69 years) from southeast
Sweden donated blood samples. The majority
of those with high fish consumption were
professional ﬁshermen. In 1993, blood sam-
ples were drawn from 67 Latvian men (medi-
an age 48 years, range 24–79 years). All of
those with high ﬁsh consumption were coastal
fishermen from fishing villages around the
Gulf of Riga. The others had varying occupa-
tions and were recruited from the general
population in Riga and four small villages in
the Latvian inland. These samples were origi-
nally taken to investigate possible immunosu-
pression or endocrine disruption due to high
consumption of ﬁsh contaminated with OHS
(26–28). Venous blood sampling was per-
formed in the morning before the subjects
had done any major physical activity. Blood
was collected in tubes containing heparin, and
the plasma was stored frozen. Each subject
was interviewed concerning his average con-
sumption of different kinds of ﬁsh, using a
food-frequency technique (29). For stratiﬁed
analyses we categorized the subjects with
respect to their consumption of fatty fish
from the Baltic Sea as follows: “none or low,”
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Table 1. Reference compounds used for analyses of organohalogen substances in human plasma samples.
Substance Abbreviation Reference
Polychlorinated biphenyls (PCBs)
2,3,3´,4,4´-Pentachlorobiphenyl CB-105 a
2,3´,4,4´,5-Pentachlorobiphenyl CB-118 (21)b
2,2´,3,3´,4,5-Hexachlorobiphenyl CB-129 a
2,2´,3,4,4´,5´-Hexachlorobiphenyl CB-138 a
2,2´,3,4´,5,5´-Hexachlorobiphenyl CB-146 a
2,2´,4,4´,5,5´-Hexachlorobiphenyl CB-153 (21)b
2,3,3´,4,4´,5-Hexachlorobiphenyl CB-156 (21)b
2,3,3´,4,4´5´-Hexachlorobiphenyl CB-157 a
2,3´,4,4´,5,5´-Hexachlorobiphenyl CB-167 a
2,2´,3,3´,4,4´,5-Heptachlorobiphenyl CB-170 a
2,2´3,3´,4´,5,6-Heptachlorobiphenyl CB-177 (21)b
2,2´,3,4,4´,5,5´-Heptachlorobiphenyl CB-180 a
2,2´,3,4,4´,5´,6-Heptachlorobiphenyl CB-183 (21)b
2,2´,3,4´,5,5´,6-Heptachlorobiphenyl CB-187 a
2,3,3´,4,4´,5,5´-Heptachlorobiphenyl (IS) CB-189 (21)b
Methoxy-PCBs
4-Methoxy-2,3,3´,4´,5-Pentachlorobiphenyl 4-MeO-CB107 (22)b
3-Methoxy-2,2´,3´,4,4´,5-Hexachlorobiphenyl 3´-MeO-CB138 (22)b
4-Methoxy-2,2´,3,4´,5,5´-Hexachlorobiphenyl 4-MeO-CB146 (22)b
3-Methoxy-2,2´,4,4´,5,5´-Hexachlorobiphenyl 3-MeO-CB-153 (22)b
4-Methoxy-2,2´,3,4´,5,5´,6-Heptachlorobiphenyl 4-MeO-CB187 (22)b
4-Methoxy-2,3,3´,4´,5,5´,6-Heptachlorobiphenyl (I.S.) 4-MeO-CB193 (22)b
Miscellaneous compounds
2,2´,4,4´-Tetrabromodiphenyl ether BDE-47 (23)b
2,2´,3,3´,4,4´-Hexabromodiphenyl ether (I.S.) BDE-128 (23)b
1,1-dichloro-2,2-bis(4-chlorophenyl)-ethene 4,4´-DDE c
1,1,1-Trichloro-2,2-bis(4-chlorophenyl)-ethane 4,4´-DDT c
Hexachlorobenzene HCB d
2,3,4-Trichlorophenol 2,3,4-triCP e
Pentachlorophenol PCP f
IS, internal surrogate standard.
aProChem GmbH, Wesel, Germany. bSynthesized as described. cSigma-Aldrich Chemie GmBH, Steinheim, Germany. dDr
Ehrenstorfer GmbH, Augsburg, Germany. eJanssen Chimica, Beerse, Belgium. fKebo, Stockholm, Sweden.0–1 ﬁsh meals/month, “moderate,” 2–11 ﬁsh
meals/month, and “high,” ≥ 12 fish
meals/month (Table 2). This stratification
provided reasonable numbers of subjects in
each category. Informed consent was obtained
from all participating subjects, and the study
was approved by the Ethics Committee of
Lund University.
Clean-up and analysis. The procedure
for extraction of the OHS from plasma has
been described fully elsewhere (30). The
extracts were evaporated to dryness and their
lipid content determined gravimetrically. In
addition, plasma lipid content was also
determined enzymatically as the sum of the
cholesterol, triglyceride, and phospolipids
present (31). The lipid content determined
enzymatically was on the average 20% high-
er (SD 13, n = 110) than that determined
gravimetrically. However, least square regres-
sion analysis revealed good agreement
between the values obtained using these two
different procedures (r2 = 0.75). We used
the enzymatically determined values for
expressing OHS concentrations per lipid
weight. Neutral compounds were separated
from acidic substances by partitioning with
0.5 M potassium hydroxide in 50% ethanol.
After subsequent acidiﬁcation of the aqueous
phase with 2 M HCl, acidic compounds
were extracted into hexane/MTBE (1:1).
The acidic fraction was subsequently deriva-
tized, after which both the neutral and acidic
fractions were treated with concentrated sul-
furic acid to remove lipids. This treatment
with sulfuric acid was repeated a second time
for the acidic fraction. The neutral fraction
was then subjected to cleanup using a silica
gel/sulfuric acid column (2:1 w/w, 0.5 g),
with hexane as the mobile phase, before
analysis. BDE-47 was analyzed by GC/MS
(ECNI) and the other substances by GC-
ECD. Blank samples (n = 6) were run in par-
allel. Quantitation of BDE-47 was carried out
only in those cases where the amount of this
substance in the plasma sample was at least
twice that in the blank. For BDE-47, the
limit for quantitation (0.1 ng/g lipid weight)
was thus directly related to the blank level.
The levels of the remaining compounds ana-
lyzed by GC-ECD were well above the limits
of quantification, and no interference was
observed. Recovery of the internal surrogate
standards CB-189, 4-OH-CB193, and 2,3,4-
triCP was 86% (SD 7.5, n = 110), 84% (SD
13, n = 110) and 80% (SD 12, n = 110),
respectively. After the completion of the pre-
sent study, phenolics used as internal surro-
gate standards were observed to adsorb to
glass during preparation of these standards.
Reanalysis of selected samples, using a volu-
metric standard, showed that this discrepancy
resulted in an overestimation of the OH-PCB
concentration by a factor of less than 3.
Statistical evaluation. We used the
Mann-Whitney U-test to test group differ-
ences. Spearman’s rank correlation coeffi-
cients were calculated to compare the 
concentrations of each OHS and fish con-
sumption and age. We performed multiple
regression analyses using the logarithms of
the OHS values, adjusting for ﬁsh consump-
tion, age, and country of origin. All p-values
< 0.05 were considered as signiﬁcant.
Results
The plasma concentrations of 14 PCB con-
geners, 5 OH-PCBs, BDE-47, 4,4´-DDE,
4,4´-DDT, HCB, and PCP in Latvian and
Swedish males, stratified on fish consump-
tion habits, are presented in Table 3. With
the exception of PCP, the plasma concentra-
tions of all the OHS were signiﬁcantly corre-
lated to the estimated ﬁsh consumption (rs =
0.55–0.70). In contrast, PCP levels were
inversely correlated to ﬁsh consumption (rs =
–0.37). Bivariate analyses revealed that age
was positively correlated with the levels of all
OHS (rs = 0.26–0.51), again with the excep-
tion of PCP. 
Multiple regression analysis including all
subjects conﬁrmed a signiﬁcant positive effect
of ﬁsh consumption on the plasma levels of
all OHS, except PCP (Table 4). The ΣPCB
level increased by 7% [95% conﬁdence inter-
val (CI), 6–9] with each additional ﬁsh meal
per month. The most pronounced relative
impact of ﬁsh consumption was observed for
BDE-47, which increased by 13% (CI, 9–16)
with each additional fish meal per month.
The relative effects of ﬁsh consumption and
age on the levels of 4,4´-DDE, 4,4´-DDT,
and HCB were all similar to that observed for
ΣPCB. The association between age and
plasma level of BDE-47 observed in the
bivariate analysis was no longer seen when
the multivariate model was applied, but the
other age-related associations remained. The
ΣPCB levels increased by 2% (CI, 1–3) for
each additional year of age including all the
subjects. Multiple regression analysis revealed
that the plasma level of ΣPCB in Latvian
men was on average 70% (CI, 57–86) of the
corresponding Swedish level, whereas the
ΣOH-PCB levels in the Latvian and Swedish
samples did not differ. The levels of CB-105
and CB-118 were 66% (CI, 26–120) and
34% (CI, 5–72), respectively, higher in the
Latvian than in the Swedish males. Similarly,
the levels of 4-OH-CB107, a metabolite of
CB-105 and CB-118 (32), was 94% (CI,
42–165) higher in Latvian than in Swedish
males. The effects of country of residence on
the levels of the other individual PCB and
OH-PCB congeners studied were similar to
those observed in the case of ΣPCB and
ΣOH-PCB, respectively. Swedish men had
higher plasma levels of PCP but lower levels
of 4,4´-DDE and 4,4´-DDT, whereas the
HCB and BDE-47 levels did not differ sig-
nificantly between the two countries. The
variance explained by the three independent
variables (ﬁsh consumption, age, and coun-
try) varied for the different OHS between
29% and 62%, with 4,4´-DDT being the
lowest and ΣPCB the highest.
To investigate the age effect within each
ﬁsh consumption group in more detail, sepa-
rate multiple regression analyses for each
group were performed with respect to the
OHS studied, except PCP (data not shown).
Using this approach, influence of age on
plasma levels of these OHS was apparent
only in men with a high dietary intake of
fish. Weak age-related associations with
OHS levels among subjects with a lower ﬁsh
consumption cannot, however, be ruled out
because of the relatively small number of
subjects in each group. Age did not affect the
plasma levels of BDE-47, irrespective of the
levels of fish consumption. This lack of
effect of age on BDE-47 concentration is
illustrated in Figure 1 and contrasted to the
inﬂuence of age on CB-153.
The correlation coefﬁcient for the com-
parisons of 4-OH-CB107 with the sum level
of its potential parent compounds (CB-105
and CB-118; rs = 0.70) was higher than the
median correlation of the 4-OH-CB107 level
to all possible sums of two PCB congeners (rs
= 0.59, 90th percentile, 0.70). In contrast,
other correlation coefficients between the
level of an OH-PCB to its potential parent
compound(s) (6,32) were all close to the
median correlation coefﬁcient for each OH-
PCB to any other PCB or to all possible
combinations of two PCB congeners
[depending on whether these are one or two
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Table 2. Age and consumption of fatty ﬁsh from the Baltic Sea for the Latvian and Swedish males involved
in the present study.
Nationality and ﬁsh Age (years) Fatty ﬁsh (meals/month)
consumption groups No. Median Range Median Range
Latvian
None or low 19 43 27–64 0 0–1
Moderate 22 45 31–64 4 2–11
High 26 55 24–79 19 13–32
Swedish
None 20 37 23–62 0 0
Moderate 11 51 34–69 8 4–8
High 12 48 23–63 16 12–20potential parent PCBs; data not shown; i.e.,
3´-OH-CB138 and CB-138; 3-OH-CB153
and CB-153; 4-OH-CB146 and Σ(CB-138,
CB-153); and 4-OH-CB187 and Σ(CB-183,
CB-187)]. Furthermore, in addition to the
variation in 4-OH-CB107 levels discussed
above, individual differences in the relative
distribution of OH-PCB congeners were
observed. This can be illustrated by the fact
that the ratio of 3-OH-CB153/4-OH-
CB146 concentration ranged from 0.15 to
1.35 (mean 0.40) for the Swedish population
and from 0.15 to 0.80 (mean 0.27) for the
Latvian population. This difference between
the two countries was signiﬁcant (p < 0.01).
Discussion 
The present study was performed using blood
samples drawn from men with different levels
of consumption of fatty ﬁsh from the Baltic
Sea. These samples were originally taken to
investigate possible immunosupression or
endocrine disruption due to high consump-
tion of ﬁsh contaminated with OHS (26–28),
but no clearcut effects were observed. Even
though these samples were obtained in the
early 1990s, they are still suitable not only for
determining OHS concentrations but also for
examining the relative inﬂuence of ﬁsh con-
sumption, age, and country of residence on
these concentrations. Previous studies have
shown that frequent consumption of fatty ﬁsh
from the contaminated Baltic Sea results in
higher plasma levels of OHS such as PCBs,
4,4´-DDE, and 4,4´-DDT (9). 
The analytical procedure used was
designed to quantitate both neutral and phe-
nolic OHS. The cleanup was based on a
procedure developed recently for the analysis
of both of these classes of environmental con-
taminants in human blood (30). GC-ECD
was used to quantitate all the compounds,
with the exception of BDE-47, which, due to
its low concentrations, had to be quantitated
by GC/MS (ECNI) (25). 
The range of BDE-47 levels in the plas-
ma of all individuals analyzed here was
< 0.1–11 ng/g lipid weight, which can be
compared to 22–2,300 ng/g lipid weight for
the major PCB congener, CB-153. A recent
study found median plasma levels of BDE-47
in female hospital cleaners and clerks from
the south of Sweden (sampled in 1997) to be
1.6 and 1.5 ng/g lipid weight, respectively
(33). Swedish mother’s milk from the same
year has been reported to contain 2.3 ng
BDE-47/g lipid weight (13), which is similar
Articles • Sjödin et al.
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Table 3. Concentrations (ng/g lipid weight) of neutral and phenolic organohalogen compounds in the plasma of Latvian and Swedish men with different dietary
consumptions of fatty ﬁsh from the Baltic Sea. 
None/low ﬁsh consumption Moderate ﬁsh consumption High ﬁsh consumption
Latvia Sweden Latvia Sweden Latvia Sweden
Compound Median (10–90%)a Median (10–90%)a Median (10–90%)a Median (10–90%)a Median (10–90%)a Median (10–90%)a
Polychlorinated biphenyls
CB-105 9 (4.4–16) 2.5 (1.7–10) 9.7 (3.0–37) 13 (3.3–25) 43 (16–60) 16 (7.2–36)
CB-118 43 (19–66) 16 (7.4–51) 39 (14–120) 56 (16–110) 200 (61–250) 67 (37–180)
CB-129 3.6 (2.2–8.1) 9.8 (4.9–18) 4.6 (3.0–20) 18 (13–39) 28 (9.6–50) 19 (12–40)
CB-138 120 (76–180) 160 (80–300) 110 (72–570) 360 (260–620) 730 (260–1,500) 360 (30–840)
CB-146 13 (7.2–22) 18 (8.7–43) 15 (8.4–64) 46 (27–97) 95 (32–180) 49 (29–110)
CB-153 160 (100–230) 220 (120–390) 130 (93–660) 410 (340–730) 920 (320–1,700) 450 (280–1,000)
CB-156 20 (12–29) 24 (12–49) 20 (13–73) 44 (40–96) 90 (32–150) 43 (20–98)
CB-157 5.9 (2.9–9.5) 3.1 (1.5–7) 5.5 (3.3–16) 6.4 (5.1–12) 23 (8.0–37) 6.9 (3.5–15)
CB-167 6.3 (3.8–11) 5.5 (3.3–16) 6.1 (3.4–24) 19 (8.3–38) 42 (15–59) 19 (13–41)
CB-170 31 (15–60) 74 (37–120) 36 (20–120) 120 (96–230) 160 (54–240) 110 (83–270)
CB-177 8.7 (5.3–12) 21 (8.6–35) 11 (5.9–41) 42 (25–90) 51 (16–89) 42 (29–81)
CB-180 74 (42–160) 160 (84–260) 87 (51–350) 280 (210–540) 420 (150–820) 260 (180–540)
CB-183 7.9 (5.7–13) 18 (10–31) 8.4 (6.2–38) 34 (28–57) 43 (19–76) 38 (26–67)
CB-187 34 (16–72) 37 (16–76) 58 (24–120) 78 (40–180) 120 (54–210) 90 (60–210)
ΣPCB 550 (340–890) 780 (390–1,400) 520 (380–2,100) 1,500 (1,200–2,800) 3,000 (1,000–5,300) 1,600 (1,000–3,600)
Polychlorobiphenylols
4-OH-CB107 82 (31–150) 36 (15–110) 73 (30–490) 78 (31–150) 290 (87–770) 58 (27–290)
3’-OH-CB138 18 (9.1–33) 20 (7.5–45) 20 (9.6–72) 43 (17–66) 74 (29–230) 28 (14–68)
4-OH-CB146 31 (17–62) 39 (12–140) 44 (20–240) 100 (55–170) 160 (57–540) 66 (43–290)
3-OH-CB153 12 (7.3–28) 15 (5.1–31) 16 (7.2–68) 30 (14–44) 57 (16–280) 20 (11–51)
4-OH-CB187 34 (23–61) 74 (54–110) 55 (27–140) 120 (62–170) 120 (66–430) 68 (57–280)
ΣOH-PCB 200 (105–290) 180 (95–450) 230 (110–1,000) 350 (180–750) 750 (270–2,200) 240 (170–980)
Miscellaneous compounds
BDE-47b 0.26 (< 0.1–0.72) 0.4 (< 0.1–2.5) 0.65 (< 0.1–6.3) 1.8 (0.19–4.5) 2.4 (1.4–5.5) 2.2 (0.96–5.7)
4,4’-DDE 660 (250–2,200) 290 (140–900) 680 (210–2,400) 960 (530–1,800) 2,200 (850–4,200) 1,100 (330–3,900)
4,4’-DDT 40 (6.8–240) 15 (5.1–48) 59 (17–230) 53 (20–110) 100 (33–200) 43 (24–110)
HCB 71 (29–160) 44 (25–81) 70 (27–150) 86 (64–130) 240 (110–410) 100 (60–150)
PCP 610 (240–3,400) 1,600 (600–5,000) 420 (170–820) 720 (460–1,400) 330 (140–1,500) 1,100 (760–1,800)
aPercentile range. bValues corrected for interference present in blank samples.
Table 4. The relative effects of age, ﬁsh consumption, and country of origin on the levels of organohalogen compounds in the plasma of Latvian and Swedish men
as determined by multiple regression analysis. 
Fish consumption Age Countrya Adjusted
Compound exp(B) 95% CI p exp(B) 95% CI p exp(B) 95% CI pR 2
ΣPCB 1.07 1.06–1.09 < 0.001 1.02 1.01–1.03 < 0.001 0.70 0.57–0.86 < 0.001 0.62
ΣOH-PCB 1.06 1.04–1.08 < 0.001 1.02 1.00–1.03 0.01 1.09 0.85–1.41 0.49 0.45
BDE-47 1.13 1.09–1.16 < 0.001 1.00 0.98–1.02 0.75 0.69 0.45–1.07 0.1 0.43
4,4’-DDE 1.06 1.04–1.08 < 0.001 1.02 1.01–1.04 < 0.001 1.37 1.01–1.86 0.05 0.45
4,4’-DDT 1.04 1.02–1.07 < 0.001 1.02 1.01–1.04 0.01 1.69 1.15–2.49 0.01 0.29
HCB 1.05 1.04–1.07 < 0.001 1.01 1.00–1.03 0.02 1.25 0.97–1.60 0.08 0.44
PCP 0.98 0.96–0.99 0.01 1.00 0.99–1.02 0.68 0.38 0.29–0.51 < 0.001 0.34
aDistinct variable, the value 1 was used for Latvia and 0 for Sweden.to the levels obtained for the Latvian and
Swedish men with no or low intake of fatty
fish and lower than the levels of all other
OHS. The largest relative effect of fatty ﬁsh
consumption was observed for BDE-47,
indicating that consumption of such ﬁsh is a
major route of exposure for high consumers. 
Meironyté et al. (13) found increasing
levels of BDE-47 in human milk during the
period 1972–1997, but the plasma levels of
BDE-47 in the present study were not related
to age, in contrast to PCBs and DDT (Figure
1, Table 4). The absence of an age-depen-
dent increase in the plasma levels of BDE-47
(Figure 1) may be a reflection of the later
introduction of PBDEs in the ecosystems.
This is supported by increasing levels of
BDE-47 in guillemot eggs from Stora Karlsö
in the Baltic Sea until the early 1990s, after
which the concentrations leveled off but
showed large between-year variations (34). It
is thus reasonable that the subjects in the pre-
sent study were mainly exposed to BDE-47
during the years preceding the blood sam-
pling, which diminishes the possibility of
detecting an accumulation in body burden
with age. Another possible explanation for
the absence of any obvious age effect would
be that BDE-47 has a much shorter half-life
than that of CB-153, for example. Thus, a
more rapid turnover of BDE-47 would lead
to a steady-state situation that would be
reached rather quickly, and no increase
should be expected thereafter. However,
BDE-47 seems to be a highly persistent
PBDE congener because this is the major
compound detected in all humans and
wildlife analyzed, whereas other PBDE con-
geners are not (35). BDE-47 and 2,2´,4,4´,5-
tetrabromodiphenyl ether (BDE-99) are both
present in similar concentrations in commer-
cial PBDE products (36), but the latter is a
minor constituent in biota (35).
The OHS found at highest levels in
human plasma here was 4,4´-DDE, the
highly persistent major metabolite of 4,4´-
DDT. The plasma levels of 4,4´-DDT and
4,4´-DDE were strongly correlated with
both fish consumption and age (Table 4).
These two contaminants were also present in
larger amounts in Latvian than in Swedish
men. This ﬁnding is consistent with reports
on 4,4´-DDE levels in perch from Latvian
waters, which indicate local sources of this
compound in the Riga area (37,38). The
concentration of 4,4´-DDE in Swedish men
with a low ﬁsh consumption observed here is
comparable to the mean 4,4´-DDE level of
260 ng/g lipid weight in mother’s milk from
the Stockholm region in 1991 (12).
Considerably higher levels have been report-
ed from areas where DDT is still in use,
especially in developing countries (39). The
population half-life of ΣDDT, calculated on
the basis of published levels in human milk
in countries where the use of DDT is either
banned or restricted, is 4.2–5.6 years (39). 
In the multiple regression analysis per-
formed on each fish consumption group
separately (data not shown), a significant
effect of age on the levels of ΣPCB, 4,4´-
DDE, 4,4´-DDT, and HCB remains for
those with a high dietary intake of fatty ﬁsh
from the Baltic Sea (compare the age-
dependent increase in CB-153 level in the
group with high ﬁsh consumption in Figure
1). No such effect was apparent among men
with moderate or low consumption of fatty
ﬁsh from the Baltic Sea. These observations
indicate that the age effect is dependent on
ﬁsh consumption (aging in combination with
ﬁsh consumption results in increasing plasma
levels of OHS). Furthermore, the rates of
uptake and elimination seem to be similar in
men with a moderate or low ﬁsh consump-
tion, leading to a steady-state situation with
respect to the levels of ΣPCB, 4,4´-DDE,
4,4´-DDT, and HCB. At the same time, it
may be noted that the concentrations of these
OHS in the fish consumed have decreased
since the 1970s (8). This may have exaggerat-
ed the observed age effect because the older
men have consumed ﬁsh with higher OHS
concentrations than the younger men.
Whereas neutral lipophilic contaminants
such as 4,4´-DDE are present in blood pri-
marily as a consequence of equilibrium with
lipid-rich tissues (40), PCP is mainly retained
in the blood due to binding to albumin and
TTR (41). The PCP level in plasma was
inversely related to ﬁsh consumption and not
affected by age, but was strongly correlated
with the country in which the subjects lived,
with the PCP levels being much lower in
Latvia than in Sweden. Obviously, consump-
tion of ﬁsh is not a major source of exposure
to PCP. This conclusion is supported by the
low concentration of this compound in ﬁsh
muscle, in contrast to the higher concentra-
tions seen in fish blood (7). Further, the
group with low fish consumption demon-
strated levels of PCP that were approximately
50% of the corresponding levels in Swedish
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Figure 1. Plasma levels of (A) BDE-47 and (B) CB-153 in relationship to age for the three groups of men with different ﬁsh consumption: none or low (0–1 ﬁsh
meals/month), moderate (2–11 ﬁsh meals/month), or high (> 12 ﬁsh meals/month). lw, lipid weight. Spearman’s rank correlation coefﬁcients and levels of signiﬁ-
cance are Rs = –0.03, p > 0.5; Rs = 0.00, p > 0.5; and Rs = 0.28, p = 0.10 for BDE-47; and Rs = 0.00, p > 0.5; Rs = 0.22, p > 0.20; and Rs = 0.71, p > 0.001 for CB-153 for low,
moderate, and high consumption, respectively. 
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Figure 2. Structures of the predominant polychlorobiphenylols present in human blood.
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metabolized to PCP to some extent, but this
does not explain the high levels of PCP pre-
sent in blood because the level of HCB was
inversely correlated to that of PCP (rs =
–0.29, p < 0.05). Clearly, there must be other
sources of PCP in the environment which
remain to be identiﬁed. It can be speculated
that exposure to PCP, due to its use as a wood
preservative, occurs via indoor air (42). The
use of PCP was banned in Sweden in 1975.
The present study has partly focused on
determining the patterns and levels of OH-
PCBs in the plasma of humans with different
levels of ﬁsh consumption and, accordingly,
different body burdens of PCB. Similar to
PCP, OH-PCBs are retained in the blood
plasma as a result of protein binding, primar-
ily to TTR (15). The OH-PCB congeners
are retained at relatively high concentrations
compared to ΣPCB in the blood (Table 3),
even though the mechanism of accumulation
is different. The PCB congeners are accumu-
lated in the fat, whereas the OH-PCBs are
bound to plasma proteins. The retention of a
cluster of OH-PCBs in human plasma was
ﬁrst reported in 1994 (17). Additional infor-
mation has since been presented (6), and
recently an additional number of OH-PCB
congeners present in human blood have been
identiﬁed (43). A total of 30 OH-PCB con-
geners have been observed in human blood
plasma (6), of which the ﬁve OH-PCB con-
geners (Figure 2) quantified here represent
the major metabolites in human plasma.
The higher plasma levels of 4-OH-
CB107 determined in Latvian men is most
probably due to their higher plasma levels of
the corresponding parent compounds CB-
105 and CB-118, as indicated by the high
correlation coefficient for the parent PCBs
and OH-PCB metabolite. The other OH-
PCB congeners quantiﬁed are formed from
the more persistent PCB congeners, CB-138,
CB-153, and CB-187, as shown by in vivo
experiments (6,32). These latter PCB con-
geners were not observed to have better corre-
lation coefﬁcients than the median correlation
coefficient for each OH-PCB to any other
PCB or to all possible combinations of two
PCB congeners (depending on whether these
are one or two potential parent PCBs). This is
most likely due to the strong intercorrelation
of these stable and persistent PCBs, which
may be contrasted to the large differences
observed between Latvian and Swedish men
for the levels of CB-105 and CB-118. 
The relative abundance of the major
OH-PCBs in the plasma varies between
individuals, as exempliﬁed by the ratio of 3-
OH-CB153 to 4-OH-CB146. The reasons
for such individual variations are not yet
known. The high afﬁnity of these OH-PCBs
for the plasma transport protein TTR, with
competing potencies of 4–14 times relative
to thyroxin, can hardly explain these differ-
ences because TTR is constitutively expressed
(15). With a slow rate of formation, evi-
denced by the persistence of the parent PCBs
and relatively high plasma levels, the OH-
PCBs seem to have long half-lives. The for-
mation of OH-PCBs is catalyzed by
cytochrome P450s (44) and variations in
individual expression of enzymes, and there-
by metabolic capacity may, in part, explain
the variations. The pharmacokinetic behavior
of OH-PCBs is almost completely unknown,
and further studies are necessary to explain
the observed variations in individual OH-
PCB patterns. 
It remains unclear whether high concen-
trations of OH-PCBs exert toxic effects on
humans and/or wildlife. It is, however,
known that OH-PCBs can competitively
inhibit binding of T4 to TTR, as well as
inhibit type I deiodinase activity (45,46).
OH-PCBs have also been shown to act as
inhibitors of T2 sulfotransferase activity in
vitro (47). A weak negative correlation
between the levels of CB-153 in plasma and
total T3 in serum in ﬁshermen’s wives from
the Swedish Baltic Sea area was recently
reported (48). It is notable that the levels of
OH-PCBs are in the same range as the PCBs
concentrations. Further work is in progress
to determine the impact these PCB metabo-
lites may have in humans and wildlife. The
PBDE concentrations are much lower than
those of PCBs and OH-PCBs, but because
the levels seem to increase in humans (13), it
is of concern that this is a serious contamina-
tion of the environment. Recently PBDEs
and hydroxylated PBDEs have been indicat-
ed to have effects on the endocrine systems
(49–51). More detailed knowledge is neces-
sary to better assess the toxicological impact
that this class of environmental contami-
nants may have. 
In conclusion, consumption of fatty ﬁsh
from the Baltic Sea has a signiﬁcant inﬂuence
on the plasma levels of neutral OHS and
OH-PCBs, but not of PCP. The low plasma
levels of BDE-47 observed were strongly
related to ﬁsh consumption, which indicates
a need for further information concerning
dietary exposure of the population in the
Baltic Sea region to PBDEs. An impact of
ﬁsh consumption on plasma OH-PCB levels
was also seen, and studies are now required to
determine whether this represents a potential
risk to human health.
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